Literature DB >> 16157222

Conditional hepatocarcinogenesis in mice expressing SV 40 early sequences.

Dan-Qing Lou1, Thierry Molina, Myriam Bennoun, Arlette Porteu, Pascale Briand, Virginie Joulin, Mireille Vasseur-Cognet, Catherine Cavard.   

Abstract

We closely mimicked the in vivo setting in which sporadic hepatocarcinoma occurs by establishing a transgenic mouse model carrying regulatable SV40 early sequences under the control of the regulatory sequences of the human antithrombin III gene that confer hepatic expression. In this system, floxed dormant oncogenic sequences became functional after excision due to adenoviral expression of Cre recombinase or the stable transgenic expression in liver of a tamoxifen-inducible Cre. Hepatic oncogene expression was switched on by both methods, leading to the development of hepatocellular carcinoma. This model could be useful for investigating the key steps of the preneoplastic process, to identify suitable targets for the testing of new therapies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157222     DOI: 10.1016/j.canlet.2004.12.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

Review 1.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

2.  Hepatocarcinogenesis in FXR-/- mice mimics human HCC progression that operates through HNF1α regulation of FXR expression.

Authors:  Nian Liu; Zhipeng Meng; Guiyu Lou; Weiping Zhou; Xiaoqiong Wang; Yunfeng Zhang; Lisheng Zhang; Xiyong Liu; Yun Yen; Lily Lai; Barry M Forman; Zhonggao Xu; Rongzhen Xu; Wendong Huang
Journal:  Mol Endocrinol       Date:  2012-04-02

Review 3.  Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers.

Authors:  Xiaomei Hou; Yan Du; Yang Deng; Jianfeng Wu; Guangwen Cao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 4.  Mouse models in liver cancer research: a review of current literature.

Authors:  Martijn W H Leenders; Maarten W Nijkamp; Inne H M Borel Rinkes
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

Review 5.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

Review 6.  Association Between Simian Virus 40 and Human Tumors.

Authors:  John Charles Rotondo; Elisa Mazzoni; Ilaria Bononi; Mauro Tognon; Fernanda Martini
Journal:  Front Oncol       Date:  2019-07-25       Impact factor: 6.244

Review 7.  Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.

Authors:  Gang Wang; Qian Wang; Ning Liang; Hongyuan Xue; Tao Yang; Xuguang Chen; Zhaoyan Qiu; Chao Zeng; Tao Sun; Weitang Yuan; Chaoxu Liu; Zhangqian Chen; Xianli He
Journal:  Cell Death Dis       Date:  2020-05-04       Impact factor: 8.469

Review 8.  Mouse models of liver cancer: Progress and recommendations.

Authors:  Li He; De-An Tian; Pei-Yuan Li; Xing-Xing He
Journal:  Oncotarget       Date:  2015-09-15

Review 9.  Genetically Engineered Mouse Models for Liver Cancer.

Authors:  Kyungjoo Cho; Simon Weonsang Ro; Sang Hyun Seo; Youjin Jeon; Hyuk Moon; Do Young Kim; Seung Up Kim
Journal:  Cancers (Basel)       Date:  2019-12-19       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.